The Brutalist Report - business
system |
|
- Market Rally Fades Again, First Solar Earnings Shine; Tesla Stock Setting Up For Investor Day [1178d]
- Stocks moving in after-hours: Novavax, Rivian, AMC [1178d]
- AMC stock bounces around after 14th consecutive quarterly loss, fourth straight year in the red [1178d]
- Healthcare Will Cost More Than Most Retirees Have: Here's Why Medicare Isn't the Answer [1178d]
- Marqeta shares dive as first-quarter forecast comes up shy of expectations [1178d]
- Novavax Tumbles After Warning of ‘Substantial Doubt’ Over Future [1178d]
- Nio Earnings: China's Tesla Set To Report Mounting Losses, But Look For This [1178d]
- Cash Is Paying More Than Traditional Stock-Bond Portfolio [1178d]
- Billionaire Israel Englander Is Making Huge Bets on These 2 ‘Strong Buy’ Stocks [1178d]
- The 20 worst U.S. stocks in February: the biggest loser dropped 35% [1178d]
- Sarepta stock surges more than 10% as results top expectations, drug given priority review [1178d]
- These Republican Bills Want to Make Tax Cheats Richer [1178d]
- Rivian stock sinks after earnings miss, weak outlook [1178d]
- Cathie Wood: Ark Builds AMD Position, Cuts Adobe [1178d]
- HP earnings: Sales decline ‘driven by the macroeconomy,’ CEO says [1178d]
- Rivian earnings: Stock slides as its 2023 production forecast misses the mark [1178d]
- Novavax stock sheds a quarter of its value after hours following revenue miss [1178d]
- Medical Scrub Disruptor FIGS Posts 12.6% Sales Growth in Q4, Issues 2023 Guidance [1178d]
- Apollo in Talks to Buy Aerospace-Parts Maker Arconic [1178d]
- Chevron Provides Details On Capex, $75 Billion Buyback At Investor Day [1178d]
- Novavax Says There Is ‘Substantial Doubt’ Around Its Ability to Continue Operating This Year [1178d]
- Analysts See Steady Growth For Acadia Pharma's Nuplazid [1178d]
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
Previous Day